Poly(olefin sulfone)s

In this chapter, we introduce poly(olefin sulfone)s and review the recent progress on the photoinduced depolymerization of poly(olefin sulfone)s as well as their applications. Poly(olefin sulfone)s combined with photobase generators (PBGs) are depolymerized upon irradiation with light. A poly(olefin sulfone) is a 1:1 alternating copolymer of olefin monomer and sulfur dioxide in which the protons on the carbons adjacent to the sulfonyl groups can be readily abstracted by a base. This removal leads to a depolymerization chain reaction, resulting in incorporation of a photobase generating chromophore that can undergo a photoinduced unzipping reaction. During this reaction, the original olefin monomer and sulfur dioxide are regenerated from the primary chain of the poly(olefin sulfone). The photoinduced depolymerization of poly(olefin sulfone)s has been investigated for a wide variety of applications, including stereolithography, printable microcircuit fabrication, and removable adhesives

The Photorefractive Effect in Liquid Crystals

This chapter summarizes the state of the art of research regarding photorefractive liquid crystals. Photorefractive effect is of interest because it can be used to obtain dynamic holograms, based on interference between dual laser beams within a liquid crystal to generate a refractive index grating. This technique can be employed in numerous diffraction optics applications, such as optical amplifiers, phase-conjugate wave generators, 3D displays, novelty filters, and optical tomography. The photorefractive effect in liquid crystals is especially pronounced, and both ferroelectric and nematic liquid crystals have been researched for this purpose, with the former showing special promise in practical applications. As an example, ferroelectric liquid crystals have been found to readily produce a refractive index grating in conjunction with a significant gain and a formation time of 900 ms

Culture moderates the relationship between interdependence and face recognition

Recent theory suggests that face recognition accuracy is affected by people’s motivations, with people being particularly motivated to remember ingroup versus outgroup faces. In the current research we suggest that those higher in interdependence should have a greater motivation to remember ingroup faces, but this should depend on how ingroups are defined. To examine this possibility, we used a joint individual difference and cultural approach to test (a) whether individual differences in interdependence would predict face recognition accuracy, and (b) whether this effect would be moderated by culture. In Study 1 European Canadians higher in interdependence demonstrated greater recognition for same-race (White), but not cross-race (East Asian) faces. In Study 2 we found that culture moderated this effect. Interdependence again predicted greater recognition for same-race (White), but not cross-race (East Asian) faces among European Canadians; however, interdependence predicted worse recognition for both same-race (East Asian) and cross-race (White) faces among first-generation East Asians. The results provide insight into the role of motivation in face perception as well as cultural differences in the conception of ingroups

Near-Infrared Extinction in The Coalsack Globule 2

We have conducted J, H, and Ks imaging observations for the Coalsack Globule 2 with the SIRIUS infrared camera on the IRSF 1.4 m telescope at SAAO, and determined the color excess ratio, E(J-H)/E(H-Ks). The ratio is determined in the same photometric system as our previous study for the rho Oph and Cha clouds without any color transformation; this enables us to directly compare the near-infrared extinction laws among these regions. The current ratio E(J-H)/E(H-Ks) = 1.91 +- 0.01 for the extinction range 0.5 < E(J-H) <1.8 is significantly larger than the ratios for the rho Oph and Cha clouds (E(J-H)/E(H-Ks) = 1.60-1.69). This ratio corresponds to a large negative index alpha = 2.34 +- 0.01 when the wavelength dependence of extinction is approximated by a power law which might indicate little growth of dust grains, or larger abundance of dielectric non-absorbing components such as silicates, or both in this cloud. We also confirm that the color excess ratio for the Coalsack Globule 2 has a trend of increasing with decreasing optical depth, which is the same trend as the rho Oph and Cha clouds have.Comment: 13 pages, 5 figures, and 2 tables, Ap

Safety and Clinical Effects of a Muse Cell-Based Product in Patients With Amyotrophic Lateral Sclerosis: Results of a Phase 2 Clinical Trial

Amyotrophic lateral sclerosis (ALS) is characterized by progressive loss of motor neurons. Multilineage-differentiating stress-enduring (Muse) cells are unique endogenous stem cells that show therapeutic effects on motor function in ALS mouse models. We conducted a single-center open phase II clinical trial to evaluate the safety and clinical effects of repeated intravenous injections of an allogenic Muse cell-based product, CL2020, in patients with ALS. Five patients with ALS received CL2020 intravenously once a month for a total of six doses. The primary endpoints were safety and tolerability, and the secondary endpoint was the rate of change in the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R) score. In addition, serum tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), sphingosine-1-phosphate (S1P), cerebrospinal fluid chitotriosidase-1 (CHIT-1), and neurofilament light chain (NfL) levels were evaluated. The CL2020 treatment was highly tolerated without serious side effects. The ALSFRS-R score change trended upward at 12 months post-CL2020 treatment compared with that at 3 months pre-administration, but the difference was not statistically significant. Among five patients diagnosed with ALS, three exhibited a decrease in the rate of ALSFRS-R score change, one demonstrated an increase, and another showed no change. In addition, the patients’ serum IL-6 and TNF-α levels and cerebrospinal fluid CHIT-1 and NfL levels increased for up to 6 months post-treatment; however, their serum S1P levels continuously decreased over 12 months. These findings indicate a favorable safety profile of CL2020 therapy. In the near future, a double-blind study of a larger number of ALS patients should be conducted to confirm the efficacy of ALS treatment with CL2020

IRF7 mediates MCP-1 in adipocyte

Hypertrophy, associated with adipocyte dysfunction, causes increased pro-inflammatory adipokine, and abnormal glucose and lipid metabolism, leading to insulin resistance and obesity-related-health problems. By combining DNA microarray and genomic data analyses to predict DNA binding motifs, we identified the transcription factor Interferon Regulatory Factor 7 (IRF7) as a possible regulator of genes related to adipocyte hypertrophy. To investigate the role of IRF7 in adipocytes, we examined gene expression patterns in 3T3-L1 cells infected with a retrovirus carrying the IRF7 gene and found that enforced IRF7 expression induced the expression of monocyte chemoattractant protein-1 (MCP-1), a key initial adipokine in the chronic inflammation of obesity. CRISPR/Cas9 mediated-suppression of IRF7 significantly reduced MCP-1 mRNA. Luciferase assays, chromatin immunoprecipitation PCR analysis and gel shift assay showed that IRF7 transactivates the MCP-1 gene by binding to its proximal Interferon Stimulation Response Element (ISRE), a putative IRF7 binding motif. IRF7 knockout mice exhibited lower expression of MCP-1 in epidydimal white adipose tissue under high-fat feeding conditions, suggesting the transcription factor is physiologically important for inducing MCP-1. Taken together, our results suggest that IRF7 transactivates MCP-1 mRNA in adipocytes, and it may be involved in the adipose tissue inflammation associated with obesity

Questionnaire survey on the continuity of home oxygen therapy after a disaster with power outages

AbstractBackgroundAfter the Great East Japan Earthquake, oxygen-dependent patients in areas experiencing power outages could not continue home oxygen therapy (HOT) without oxygen cylinders. The purpose of this study was to examine use of oxygen cylinders in areas experiencing power outages and the effects of HOT interruption on patients' health.MethodsQuestionnaires were mailed to 1106 oxygen-dependent patients and HOT-prescribing physicians in Akita, near the disaster-stricken area. We investigated patients' actions when unable to use an oxygen concentrator and classified the patients based on oxygen cylinder use. Patients who experienced an interruption of or reduction in oxygen flow rate by their own judgment were assigned to the “interruption” and “reduction” groups, respectively; those who maintained their usual flow rate were assigned to the “continuation” group. Differences were tested using analysis of variance and the χ2 tests.ResultsIn total, 599 patients responded to the questionnaire. Oxygen cylinders were supplied to 574 patients (95.8%) before their oxygen cylinders were depleted. Comparison of the continuation (n=356), reduction (n=64), and interruption (n=154) groups showed significant differences in family structure (p=0.004), underlying disease (p=0.014), oxygen flow rate (p<0.001), situation regarding use (p<0.001), knowledge of HOT (p<0.001), and anxiety about oxygen supply (p<0.001). There were no differences in changes in physical condition.ConclusionsMost patients could receive oxygen cylinders after the disaster. Some patients discontinued their usual oxygen therapy, but their overall health status was not affected

Clinical and Pathological Benefits of Edaravone for Alzheimer's Disease with Chronic Cerebral Hypoperfusion in a Novel Mouse Model

Alzheimer's disease (AD) and chronic cerebral hypoperfusion (CCH) often coexist in dementia patients in aging societies. The hallmarks of AD including amyloid-β (Aβ)/phosphorylated tau (pTau) and pathology-related events such as neural oxidative stress and neuroinflammation play critical roles in pathogenesis of AD with CCH. A large number of lessons from failures of drugs targeting a single target or pathway on this so complicated disease indicate that disease-modifying therapies targeting multiple key pathways hold potent potential in therapy of the disease. In the present study, we used a novel mouse model of AD with CCH to investigate a potential therapeutic effect of a free radical scavenger, Edaravone (EDA) on AD with CCH via examining motor and cognitive capacity, AD hallmarks, neural oxidative stress, and neuroinflammation. Compared with AD with CCH mice at 12 months of age, EDA significantly improved motor and cognitive deficits, attenuated neuronal loss, reduced Aβ/pTau accumulation, and alleviated neural oxidative stress and neuroinflammation. These findings suggest that EDA possesses clinical and pathological benefits for AD with CCH in the present mouse model and has a potential as a therapeutic agent for AD with CCH via targeting multiple key pathways of the disease pathogenesis